finally , extracorporeal immunoadsorbent treatment was capable of attenuating the early heterologous phase of passive canine nephrotoxic nephritis and may have a potential role in the therapy of anti-gbm-mediated nephropathy .
C0027697
nephritis
C0022658
nephropathy